- Filed
- Feb 12, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 9, 2024 | 2.71M sh |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $3.6M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $2.75M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $12.14M |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $11.48M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $12.14M |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $11.62M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $45.27M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $44.68M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $50.36M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $47.5M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 2.45M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 2.45M sh |
| Capex | Q2 2024 · Dec 31, 2022 | $103.89K |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | $4.68M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $34.12M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $32.93M |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | $32.1M |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.47 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.78 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.47 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.78 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $874.93K |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $1.71M |
| Net Income | Q2 2024 · Dec 31, 2022 | $1.15M |
| Net Income | Q2 2024 · Dec 31, 2022 | $1.91M |
| Operating Income | Q2 2024 · Dec 31, 2022 | $1.39M |
| Operating Income | Q2 2024 · Dec 31, 2022 | $2.36M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $2.26M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $4.07M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $6.54M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $13.37M |
| Revenue | Q2 2024 · Dec 31, 2022 | $8.8M |
| Revenue | Q2 2024 · Dec 31, 2022 | $17.44M |